Поставщики · Производитель · Промышленная биотехнология и биоматериалы
Lesaffre
Lesaffre (Франция) более века работает в ферментации; выручка — 3,2 млрд евро, подразделения на всех континентах, 11 700 сотрудников 100 национальностей. Вместе с клиентами, партнёрами и исследователями разрабатывает продукты на основе микроорганизмов для питания и здоровья.
Профиль
- Отрасль
- Альтернативные белки, Энергетика, Оборудование для биопроизводства, Пищевые ингредиенты
- Темы
- Дрожжи, ферментация и пищевые ингредиенты
- Роль
- Производитель — “…natural/resource-efficient processes. - ** ** — Lesaffre is a global leader in fermentation and bioengineering…”
- Почему это биоэкономика
- Lesaffre производит дрожжи, ферменты и другие микроорганизмы для пищевой, медицинской и промышленной биотехнологии.
Биорешения, которые поставляет 0
Пока не указана поставщиком в решениях с доказательствами.
Что предлагают
Дочерние компании: Fermenis · Biospringer · Ennolys · Gnosis · Phileo · Agrauxine · LIS · Procelys · Leaf
Бизнес-модель · fermentation
Lesaffre is a global leader in fermentation and microorganisms, operating through two main activities: Baking and Nutrition-Health and Biotech. It sells a wide range of yeast-based products, fermentation nutrients, and natural ingredients to customers in the food, healthcare, animal nutrition, and industrial biotechnology sectors. The company earns revenue through the sale of these products, often utilizing a co-development approach with customers to create tailored, performance-based solutions.
| 2024 Lesaffre reports an annual turnover of 3 billion euros. “3 billion euros in sales” | www.lesaffre.com weak (company, news, market research, other) |
| 2024 The company holds 187 patent families and 2,844 patents under examination or issued. “Our Group has 187 patent families and 2,844 living patents currently being assessed or issued.” | www.lesaffre.com weak (company, news, market research, other) |
| 2024 Lesaffre operates 80 production sites across 55 countries and distributes products in over 180 countries. “Operating in 55 countries on all continents, Lesaffre is a world-class group that distributes its products in over 180 countries. With 80 production sites and 65 applied science centers, we have a significant presence in …” | www.lesaffre.com weak (company, news, market research, other) |
| 2024 Lesaffre has been a player in the breadmaking fermentation sector since 1853. “BAKING: as a leading player in the breadmaking fermentation sector since 1853, we believe that bread and breadmaking products provide an inexpensive source of vegetable protein and staple food items, and are among the …” | www.lesaffre.com weak (company, news, market research, other) |
| Saf Pro® Relax 200 / Deactivated Yeast Saf Pro® Relax 200 and other deactivated yeast solutions replace chemical dough relaxers like L-cysteine or protease in bakery recipes. “The glutathione liberated from the yeast cells then acts on the gluten network in the dough, functioning as a clean-label dough relaxer — replacing L-cysteine or protease in the recipe.” | lesaffre.uk weak (company, news, market research, other) |
| Saf Pro® Star-Zyme™ MDG Replacer / STR 701 R Lesaffre's enzymatic improver systems replace traditional emulsifiers like mono and diglycerides (MDGs) and DATEM in bakery applications. “Formulators can effectively replace traditional ingredients with Lesaffre’s portfolio of clean label improvers and extended shelf life solutions.” | lesaffrebaking.com weak (company, news, market research, other) |
| Natural acetoin (fermentation-based) Lesaffre is developing a fermentation-based process for natural acetoin production to replace chemical synthesis using fossil raw materials. “The current supply of commercial acetoin is largely derived from chemical synthesis using fossil raw materials.” | www.lesaffre.com weak (company, news, market research, other) |
Новости и статус 6
- 2024 Последний статус: В 2024 г. Lesaffre купила бизнес дрожжевых экстрактов dsm-firmenich и компанию Altar. ↗ ↗ ↗
- 2026-09-23 Lesaffre et le groupe ÉS, associé à Dalkia, franchissent une étape majeure dans la décarbonation industrielle du territoire strasbourgeois. - LesaffreLesaffre, via a collaboration with the ÉS group and Dalkia, launches the R2E project in Strasbourg to convert yeast-plant waste streams into renewable energy, enabling 98% heat decarbonization and preventing 35,700 tonnes of CO2 per year. The initiative …
- 2026-09-10 LIS by Lesaffre investit à Strasbourg dans de nouvelles capacités et technologies de séchageLesaffre expands LIS by Lesaffre with the integration of its Strasbourg site and the installation of fluidized bed drying tech, boosting production capacity and enabling new high-value services across Europe while sharpening strategic focus on outsourcing …
- 2026-08-27 Ennolys by Lesaffre renforce son offre de services de sous-traitance pour accélérer et dérisquer l’industrialisation des innovations durables - LesaffreLesaffre expanding Ennolys by Lesaffre’s CDMO services to accelerate and de-risk biotechnological industrialization, leveraging its fermentation expertise to support clients from R&D to large-scale production across multiple markets. It demonstrates Lesaffre’s …
- 2026-07-10 Lesaffre salue les avancées majeures en matière de normalisation internationale de la levure de panification - LesaffreLesaffre welcomes major international standardization advances for bread yeast, highlighting its role as a key, globally recognized ingredient. It credits collaboration with COFALEC and the Codex Alimentarius and ISO 23983:2025 for creating a common regulatory …
- 2026-10-02 Lesaffre lance un projet visant à décarboner 98 % de la chaleur de l'un de ses sites en région Grand Est - Portail officiel de la bioéconomie en Grand EstLesaffre lance le projet R2E à Strasbourg avec le groupe ÉS et Dalkia pour décarboner 98 % de la chaleur du site, produire 168 GWh de chaleur décarbonée et éviter 35 700 tonnes de CO₂ par an tout en réduisant la consommation d’eau.
- 2026-09-14 Levures et probiotiques : l'innovation en nutrition canine - LesaffreLesaffre, via Phileo and LIST, is advancing canine nutrition by using in vitro models to trace how ingredients like yeast probiotics and alternative proteins survive digestion and interact with the canine gut microbiome. Their work aims to uncover mechanistic …
Связи: владельцы, партнёры, аналоги
Владельцы и инвесторы 9
| дочерняя | Fermenis |
| дочерняя | Biospringer |
| дочерняя | Ennolys |
| дочерняя | Gnosis |
| дочерняя | Phileo |
| дочерняя | Agrauxine |
| дочерняя | LIS |
| дочерняя | Procelys |
| дочерняя | Leaf |
Партнёры и сделки 2
| сторона сделки | dsm-firmenich’s yeast extract business (acquired 2024) …Lesaffre completed the acquisitions of dsm-firmenich’s yeast extract business and the company Altar in 2024.… |
| сторона сделки | Altar (acquired 2024) …Lesaffre completed the acquisitions of dsm-firmenich’s yeast extract business and the company Altar in 2024.… |
Похожие компании
Ohly · Corbion · Prosol · Algist Bruggeman · EUROLYSINE · Leiber GmbH · Lallemand Specialty Cultures · Corden BioChem
Реквизиты и контакты
Контакты, руководители и юридические данные доступны участникам.
Войти как участник